Prostacyclin (PGI2) and the effect of phosphodiesterase inhibitors on platelet aggregation
- 1 July 1979
- journal article
- research article
- Published by Elsevier in Pharmacological Research Communications
- Vol. 11 (7), 605-615
- https://doi.org/10.1016/s0031-6989(79)80032-6
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- RECIRCULATION OF PROSTACYCLIN (PGI2) IN THE DOGBritish Journal of Pharmacology, 1978
- Chemical stability of prostacyclin (PGI2) in aqueous solutionsProstaglandins, 1978
- Circulatory and anti-platelet effects of intravenous prostacyclin in healthy menPharmacological Research Communications, 1978
- DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLINThe Lancet, 1978
- The effect of dipyridamole on platelet function: correlation with blood levels in man.British Journal of Clinical Pharmacology, 1977
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- Are agents affecting platelet functions clinically useful?American Journal Of Medicine, 1976
- Platelet Physiology and Abnormalities of Platelet FunctionNew England Journal of Medicine, 1975
- Effect of Dipyridamole and Two Pyrimido-Pyrimidine Derivatives on the Kinetics of Human Platelet Aggregation and on Platelet AdhesivenessScandinavian Journal of Clinical and Laboratory Investigation, 1969
- The Effect on Dipyridamole on Platelet Aggregation and AdhesivenessScottish Medical Journal, 1968